CDKN2A and urinary bladder cancer: The association between CDKN2A and prognosis is complicated in bladder cancer, as both p16 protein over‐expression and complete lack of expression have been shown to be biomarkers of poor prognosis in bladder cancers (Shariat et al,2004; Worst et al,2018).